Header

UZH-Logo

Maintenance Infos

Five-year outcome in immune-mediated scleritis


Bernauer, Wolfgang; Pleisch, Beat; Brunner, Matthias (2014). Five-year outcome in immune-mediated scleritis. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 252(9):1477-1481.

Abstract

Immune-mediated scleritis is a rare condition, and the information on the clinical course and complications is scarce. The aim of this study was to identify prognostic factors, complications, and therapeutic effects in patients with immune-mediated scleritis. Methods: Patients with diagnosis of scleritis and a follow-up time of 5years were identified. Systemic disease, laboratory investigations, type of scleritis, disease activity, therapy, and complications were recorded. The study design was a retrospective, non-comparative, interventional case series. Results: Systemic disease was identified in 15 (37%) patients at presentation and in 18 (45%) after 5years. Rheumatoid arthritis (15%), granulomatosis with polyangiitis (7.5%), and polychondritis (7.5%) were the most predominant disorders. Persistent scleritis (>5years) was associated with systemic disease (66 vs. 6%; p < 0.05) and positive auto-antibodies (48 vs. 23%; p = 0.18). Control of ocular inflammation was achieved in 38 of 40 (95%). Prednisone (14 patients) and/or methotrexate (8) were the predominant drugs to control persistent disease. Complications included interstitial keratitis (2), inflammatory astigmatism (2), corneal melt (3), macular edema (6), and severe systemic disease (5). Conclusion: The presence of systemic disease and positive auto-antibodies are associated with persistent scleritis. Immunosuppressive agents allow control of scleritis, but may contribute to severe systemic complications.

Abstract

Immune-mediated scleritis is a rare condition, and the information on the clinical course and complications is scarce. The aim of this study was to identify prognostic factors, complications, and therapeutic effects in patients with immune-mediated scleritis. Methods: Patients with diagnosis of scleritis and a follow-up time of 5years were identified. Systemic disease, laboratory investigations, type of scleritis, disease activity, therapy, and complications were recorded. The study design was a retrospective, non-comparative, interventional case series. Results: Systemic disease was identified in 15 (37%) patients at presentation and in 18 (45%) after 5years. Rheumatoid arthritis (15%), granulomatosis with polyangiitis (7.5%), and polychondritis (7.5%) were the most predominant disorders. Persistent scleritis (>5years) was associated with systemic disease (66 vs. 6%; p < 0.05) and positive auto-antibodies (48 vs. 23%; p = 0.18). Control of ocular inflammation was achieved in 38 of 40 (95%). Prednisone (14 patients) and/or methotrexate (8) were the predominant drugs to control persistent disease. Complications included interstitial keratitis (2), inflammatory astigmatism (2), corneal melt (3), macular edema (6), and severe systemic disease (5). Conclusion: The presence of systemic disease and positive auto-antibodies are associated with persistent scleritis. Immunosuppressive agents allow control of scleritis, but may contribute to severe systemic complications.

Statistics

Citations

Dimensions.ai Metrics
9 citations in Web of Science®
9 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

21 downloads since deposited on 07 Aug 2019
21 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:National licences > 142-005
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Ophthalmology, Sensory Systems, Cellular and Molecular Neuroscience
Language:English
Date:1 September 2014
Deposited On:07 Aug 2019 07:30
Last Modified:25 Sep 2019 00:38
Publisher:Springer
ISSN:0721-832X
OA Status:Green
Publisher DOI:https://doi.org/10.1007/s00417-014-2696-1
Related URLs:https://www.swissbib.ch/Search/Results?lookfor=nationallicencespringer101007s0041701426961 (Library Catalogue)

Download

Green Open Access

Download PDF  'Five-year outcome in immune-mediated scleritis'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 495kB
View at publisher